ArticleFrontiers in pharmacology2022

BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis.

Franziska Elena Herrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.